Literature DB >> 23959623

Transparency interrupted: the curtailment of the European Medicines Agency's Policy on access to documents.

Peter Doshi1.   

Abstract

Mesh:

Year:  2013        PMID: 23959623     DOI: 10.1001/jamainternmed.2013.9989

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  5 in total

1.  Behind closed doors.

Authors:  Laura DeFrancesco
Journal:  Nat Biotechnol       Date:  2014-06       Impact factor: 54.908

Review 2.  Views of Ethical Best Practices in Sharing Individual-Level Data From Medical and Public Health Research: A Systematic Scoping Review.

Authors:  Susan Bull; Nia Roberts; Michael Parker
Journal:  J Empir Res Hum Res Ethics       Date:  2015-07       Impact factor: 1.742

3.  Open data 5 years on: a case series of 12 freedom of information requests for regulatory data to the European Medicines Agency.

Authors:  Peter Doshi; Tom Jefferson
Journal:  Trials       Date:  2016-02-11       Impact factor: 2.279

Review 4.  Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications.

Authors:  Emma Maund; Britta Tendal; Asbjørn Hróbjartsson; Karsten Juhl Jørgensen; Andreas Lundh; Jeppe Schroll; Peter C Gøtzsche
Journal:  BMJ       Date:  2014-06-04

5.  Methodological developments in searching for studies for systematic reviews: past, present and future?

Authors:  Carol Lefebvre; Julie Glanville; L Susan Wieland; Bernadette Coles; Alison L Weightman
Journal:  Syst Rev       Date:  2013-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.